National survey shows cancer patients feel increasingly positive about their NHS care

NHS England (NHSE) has published the latest National Cancer Patient Experience Survey, 2016.

72,788 people with cancer gave their views on their care.  In particular, respondents gave an average rating of 8.74 when asked to rate their care on a scale of zero (very poor) to ten (very good).  This represents a statistically significant increase on last year's score.

The survey also identified improvements in people's opinions of their involvement in care and treatment decisions, and in their treatment with dignity and respect.

Areas for improvement, include follow up community and social care after treatment.

Professor Chris Harrison, National Clinical Director for Cancer at NHS England, commented:

“One of our key ambitions is to put cancer patient experience front and centre at a time when the NHS is successfully treating more patients for cancer than ever before, so this positive feedback from patients is an encouraging testament to the hard work of NHS staff.”

The story can be viewed on NHSE's website here and the full survey results are available here.

Page published: Fri 28 July 2017

It is supported by 9 companies:

  • Amgen
  • Bayer
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Lilly
  • Novartis
  • Pfizer
  • Roche
  • Shire